4.5 Review

Cell culture models to study retinal pigment epithelium-related pathogenesis in age-related macular degeneration

Journal

EXPERIMENTAL EYE RESEARCH
Volume 222, Issue -, Pages -

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.exer.2022.109170

Keywords

Retinal pigment epithelium; ARPE19; Primary cells; iPSC-RPE; Organ-on-a-Chip; Complement system

Categories

Funding

  1. National Eye Institute (NEI) [EY032751, EY028160, EY031748, P30 EY005722, EY026539, EY031594-01A1, EY030668, EY023299, EY027442, M2021020I, P30EY002162, EY026215]
  2. Research to Prevent Blindness/American Macular Degeneration Foundation Catalyst Award
  3. BrightFocus Foundation [EY031109, P30 EY000331]
  4. Foundation Fighting Blindness (DSW)

Ask authors/readers for more resources

Age-related macular degeneration is a disease that causes irreversible vision loss in the elderly, affecting the central part of the retina known as the macula. In vitro models of the retinal pigment epithelium (RPE) have been developed to study various aspects of AMD. However, different models show significant variations in RPE phenotype, making it necessary to establish standards for differentiating and characterizing RPE cells.
Age-related macular degeneration (AMD) is a disease that affects the macula - the central part of the retina. It is a leading cause of irreversible vision loss in the elderly. AMD onset is marked by the presence of lipid-and protein -rich extracellular deposits beneath the retinal pigment epithelium (RPE), a monolayer of polarized, pigmented epithelial cells located between the photoreceptors and the choroidal blood supply. Progression of AMD to the late nonexudative dry stage of AMD, also called geographic atrophy, is linked to progressive loss of areas of the RPE, photoreceptors, and underlying choriocapillaris leading to a severe decline in patients' vision. Differential susceptibility of macular RPE in AMD and the lack of an anatomical macula in most lab animal models has promoted the use of in vitro models of the RPE. In addition, the need for high throughput platforms to test potential therapies has driven the creation and characterization of in vitro model systems that recapitulate morphologic and functional abnormalities associated with human AMD. These models range from spontaneously formed cell line ARPE19, immortalized cell lines such as hTERT-RPE1, RPE-J, and D407, to primary human (fetal or adult) or animal (mouse and pig) RPE cells, and embryonic and induced pluripotent stem cell (iPSC) derived RPE. Hallmark RPE phenotypes, such as cobblestone morphology, pigmentation, and polarization, vary signif-icantly betweendifferent models and culture conditions used in different labs, which would directly impact their usability for investigating different aspects of AMD biology. Here the AMD Disease Models task group of the Ryan Initiative for Macular Research (RIMR) provides a summary of several currently used in vitro RPE models, his-torical aspects of their development, RPE phenotypes that are attainable in these models, their ability to model different aspects of AMD pathophysiology, and pros/cons for their use in the RPE and AMD fields. In addition, due to the burgeoning use of iPSC derived RPE cells, the critical need for developing standards for differentiating and rigorously characterizing RPE cell appearance, morphology, and function are discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available